Men and Women age 50 and over with knee pain from osteoarthritis (OA) may qualify for a free 8-week treatment study. No travel is involved; an experienced professional will come to participants' homes for assessments and treatments.
Volunteers age 50 and over with knee osteoarthritis (OA) are needed for a free study in the Tampa Bay region. Qualified participants will not have to travel; an experienced professional will come to their homes for assessments and training. This is a free-of-charge academic study conducted as part of a PhD thesis.
Participants will be randomly assigned to one of four 8-week conditions. Three of these involve 3 days per week of simple rehabilitation exercises. Each session takes about 30 minutes to complete. The fourth condition is a topical cream applied once per day. Those using the topical will continue into an exercise program at the end of 8 weeks if they choose.
An initial screening will be done by telephone. People are needed that have knee pain and mobility problems, are not exercising regularly, have not had joint replacement, and that do not have other types of arthritis (such as rheumatoid or fibromyalgia). Participant recruitment is ongoing and expected to continue through the end of 2011.
To learn more about this study, please contact Matthew Rogers at 727-642-0309 or MRogersOA@gmail.com. You may also visit www.KneeStudy.info
About the Researcher – Exercise Physiologist Matthew W. Rogers is based in Dunedin, Florida and is completing a doctorate in Human Movement Science through the Department of Biokinetics & Sport Science at The University of Zululand, South Africa. He earned a Master of Science degree from The University of Kentucky and is a Certified Strength & Conditioning Specialist. Over the past 24 years, Mr. Rogers has worked in health care, physical rehabilitation, and education. He has been conducting arthritis research in Florida since 2005. He has published his research in medical journals and has made numerous presentations at professional conferences and to the public.
The study is registered at ClinicalTrials.gov (NCT00735098).